Pleryon

Pleryon was founded in 2017 by Dr. Yu Yu and Professor Ying Zhou from the Department of Chemical and Biological Engineering at the Hong Kong University of Science and Technology. Pleryon is committed to the development of drugs for ophthalmic diseases, particularly chronic ophthalmic conditions. The company aims to address challenges in the field of ophthalmic drug treatments using its core technologies, providing patients with comfortable, convenient, and highly effective therapeutic options.